chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever 4 degrees F above normal, dizziness, nausea, soreness in right arm.
Patient reported this morning; pale, fever (99.9 - 100.8), chills, fatigue, and nausea. Patient reports throwing up a couple of times. Patient not able to eat. Patient currently napping, wife making broth and electrolyte drink (Gatorade-like drink).
blepharitis, an eyelid infection, an autoimmune condition which is triggered by overactive immune system/The infection, clogged his eyelid both top and bottom along with lash line causing bacterial overgrowth, and itchiness; he was diagnosed with strep and flu 2 weeks ago; he was diagnosed with strep; This spontaneous case was reported by a consumer and describes the occurrence of BLEPHARITIS (blepharitis, an eyelid infection, an autoimmune condition which is triggered by overactive immune system/The infection, clogged his eyelid both top and bottom along with lash line causing bacterial overgrowth, and itchiness), INFLUENZA (he was diagnosed with strep and flu 2 weeks ago) and STREPTOCOCCAL INFECTION (he was diagnosed with strep) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (blood works done to check the level of antibody they have after getting 2 doses of the Moderna Covid-19 vaccines). Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLEPHARITIS (blepharitis, an eyelid infection, an autoimmune condition which is triggered by overactive immune system/The infection, clogged his eyelid both top and bottom along with lash line causing bacterial overgrowth, and itchiness), INFLUENZA (he was diagnosed with strep and flu 2 weeks ago) and STREPTOCOCCAL INFECTION (he was diagnosed with strep). At the time of the report, BLEPHARITIS (blepharitis, an eyelid infection, an autoimmune condition which is triggered by overactive immune system/The infection, clogged his eyelid both top and bottom along with lash line causing bacterial overgrowth, and itchiness) and INFLUENZA (he was diagnosed with strep and flu 2 weeks ago) was resolving and STREPTOCOCCAL INFECTION (he was diagnosed with strep) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: blood works done to check the level of antibody / His titer 10.5 months after booster dose was 66. His doctor only told him that he has high levels of the antibodies.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Patient reporting that a few weeks after getting booster dose, which was administered in mid Nov 2021, patient was diagnosed with Blepharitis, and it was relieved after taking eye drops and steroid eye cream. He had 4 episodes since.  Patient was seeking immunogenicity information about immune response to vaccine and how it was determined that a booster dose was needed as know immune response reduces over time. He also had relief since he was diagnosed with strep and flu 2 weeks ago.  Treatment drug was not reported.
Patient received vaccine at 352pm and was in her waiting period of 15 minutes , came to the window complaining of itchy throat and tingling of face. We moved patient into immunization room and had her sit and called 9-1-1 at 400pm . She was responding and able to talk so we gave her 25mg of liquid benadryl- within 5 minutes she was complaining of itchy and tingling face gave another dose of 25mg  benadryl. EMS arrived checked patient out , vitals were ok patient signed a release to go home.
redness on 1st day p/vax;then devel a golf ball size nodule @ site;
Patient was miserable; Patient experienced a rash a week after her second booster; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Patient was miserable) and RASH (Patient experienced a rash a week after her second booster) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced FEELING ABNORMAL (Patient was miserable) and RASH (Patient experienced a rash a week after her second booster). At the time of the report, FEELING ABNORMAL (Patient was miserable) and RASH (Patient experienced a rash a week after her second booster) outcome was unknown.            No concomitant medication information was provided.  It was reported that the patient went to dermatologist. No treatment medication was provided.   Reporter did not allow further contact
No additional AE; improperly stored vaccine was administered to a patient.; This spontaneous report was received from a nurse, concerning a patient of unknown age and gender. Information regarding the patients' medical history, concurrent conditions, drug reactions or allergies, and concomitant therapies was not provided.  On an unknown date, there was a temperature excursion registered for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) of -11.8 Celsius degrees for 1 hour 45 minutes and 0 seconds. There was no previous temperature excursion reported.  On 27-SEP-2022, the patient was vaccinated with the improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, lot # W017567, expiration date reported as 29-DEC-2023, but upon internal validation established as 29-NOV-2023 (dose, route of administration, and anatomical location were not provided) administered for prophylaxis (product storage error).   No additional adverse event was reported.
About 15 days after receiving the second dose I started to hurt the calf of my left leg, I feel a constant internal tingling that to date has not disappeared.
MA gave PNEUMOVAX 23 to the wrong patient; was actually given to another, younger patient; MA calling in an adverse event on a patient; This spontaneous report was received from a medical assistant referring to a 20 year old non-pregnant female patient. The patient's pertinent medical history included both eustachian tube dysfunction, no known drug allergies were reported and her concomitant medications included unspecified birth control.     On an unknown date, the patient received a dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (Lot # T009744, expiration date 28-JAN-2022), dosage not provided, intramuscular in the left deltoid, this vaccine was intended to be administered to a different older patient.         On an unknown date, the patient experienced an unspecified adverse event. No product quality complaint  (PQC) or additional adverse events were reported. The outcome of the unspecified adverse event was unknown. The reporter considered that the experiences were not related to the product itself.
Pains; Aches; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pains), MYALGIA (Aches), HEADACHE (Headache) and PYREXIA (Fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (Pains), MYALGIA (Aches), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, PAIN (Pains), MYALGIA (Aches), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided. Concomitant medication list was not provided by the reporter. Treatment information was not provided.   The reporter wanted to know if ibuprofen, aspirin or anything could be taken to alleviate the pain.
Tiredness; Headache in the back of his head; Fever with Chills; Weight loss; chills; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox (had a very severe case of chickenpox as a child). Concurrent medical conditions included tooth abscess.   In July 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced tiredness, headache, fever chills, weight loss and chills. On an unknown date, the outcome of the tiredness and weight loss were recovering/resolving and the outcome of the headache, fever chills and chills were recovered/resolved.   It was unknown if the reporter considered the tiredness, headache, fever chills, weight loss and chills to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix approximately 3 weeks ago and had fever with chills, a headache in the back of his head, tiredness, weight loss, and other symptoms that he could not remember.  The patient was just beginning to feel better and headache, fever and chills had fully recovered.  The reporter was unclear if all symptoms were related to Shingrix as he also had 2 teeth abscess that he had to receive care for. No Lot or Expiry was provided. The reporter did not consent to follow up.
tested positive for COVID-19. Showed signs of aching, sweating, runny nose, headache and extreme tiredness; tested positive for COVID-19. Showed signs of aching, sweating, runny nose, headache and extreme tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SHINGRIX. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for COVID-19. Showed signs of aching, sweating, runny nose, headache and extreme tiredness". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Clinical course: After two Pfizer COVID-19 shots and two boosters, patient tested positive for COVID-19, showed signs of aching, sweating, runny nose, headache and extreme tiredness. Patient recently had Shingles vaccine as well. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
C/O fever 103 F after vaccine on 1/18/06. Consulted Dr who prescribed Tylenol et Motrin. Mother also reported cold symptoms at same time.
A few moments  after vaccination patient  fainted was lowered to floor by Mom and Pharmacist legs elevated, some red spots on vaccinated arm, begin a seizure type activity.  Gaged but no vomiting, heavy breathing.  Patient came back around after a few minutes.  The mother and patient stayed about 20 more minutes.  Patient  returned to normal had some cold water and snack.  The Mom mentioned the patient had fainted before with vaccination however on the consent answered that question as No.
Second dose is non Moderna Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Second dose is non Moderna Vaccine) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Sep-2021, the patient received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 13-Sep-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Second dose is non Moderna Vaccine). On 13-Sep-2021, INTERCHANGE OF VACCINE PRODUCTS (Second dose is non Moderna Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient did not had any adverse reaction or symptoms.  No concomitant medications were reported.  No treatment information was reported.
Sat 01/07/2023 was called by my mother, (90) re: patient sliding off chair to floor after shaking of right arm and unable to get up. My mother went to apt 1180 w/spouse and lifted him onto chair. patient was observed as having drooping of right side of mouth, slurred speech, flaccid right arm and right leg. 911 called. Arrived within 5 minutes and stated was probably having mild stroke. Transferred pt. immediately to a local Hospital for stoke.  Given 81mg dose aspirin. No TPA.
0950: received 1st dose of Pfizer vaccine EN6207 in right deltoid 0955: developed itchy red hive like rash in 3 areas of right arm, denied sob.  0957: received 25mg po Benadryl  Instructed patient to stay 30 minutes to be monitored.  No further issues and left after 30 minutes
Erythema multiforme 2 days after DPT-IPV-HBV, ActHib, Prevnar and Rotateq.  Also had concomitant URI and mild bronchiolitis at time of vaccinations.
Sick; This case was reported by a consumer via call center representative and described the occurrence of sickness in a 67-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were received as follows: The age at vaccination was not reported. The patient received the flu vaccine and was sick for 5 days after that. No additional details were available. The patient consented to follow up. This case has been linked to US2019227021, reported by the same reporter.
Case received from a consumer through the MIS on 30 September 2010 under the local reference number 10-0632. A 39-year-old female patient, with a medical history of autoimmune disease, had received her intramuscular dose of ADACEL (batch number and anatomical site of administration not reported) on 25 August 2010. The patient had had no illness at time of vaccination. She had no previous history of adverse event following vaccination and no other vaccine received within 4 weeks prior to 25 August 2010. The patient had had no other medication. On 03 September 2010, i.e. 9 days post-vaccination, the patient felt anxious. Her anxiety level increased little by little to a high level and had remained constant. The patient's symptoms were not resolved at the time of the report. Documents held by sender: none.
Episode of altered mental status post DTaP vaccine on 2/19/21.  Pt was also sick with fever and URI symptoms.  Unclear if symptoms were related to illness or to the DTaP vaccine.
Rapid heart beat during night at 109 (resting normally 70).  Blood pressure elevated to 180/83.  Took 2 Tylenol tabs, layed flat with feet elevated.  Blood pressure dropped to 144/70  heart beat 91.  Blood sugars consistantly over 200 (normally low at night) and within range during the day.
Patient received vaccine and was fine through her 15 minute observation period. She left the clinic and came back about 40 minutes later complaining of tingling in her tongue and weakness in her legs and felt like she needed to sit down. Her blood pressure was taken and it was elevated and a decision to take her to the ED was made. In the ED, she denied shortness of breath and did not have any other signs of anaphylaxis. She was given diphenhydramine 50 mg (at 11:36AM), famotidine 20 mg (@11:36AM) and prednisone 50 mg (at 11:43AM). At 12:23PM, documentation from the ED notes that tongue symptoms resolved, but patient still felt weak.
Information has been received from a registered nurse, concerning a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On 31-MAR-2017, the patient was vaccinated with an expired dose of M-M-R II (rHA) (lot # L009212 with expiration date 17-MAR-2017) (dose, strength, frequency and anatomical location were not provided), subcutaneously, for prophylaxis. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Rash on her right arm, size of rash is 4 inches by 2 inches; Itchy rash; Bright red rash; A spontaneous report was received from a 46 year old female patient (dental hygienist) who received Moderna's COVID-19 vaccine (mRNA-1273) and developed a rash on her right arm, size of rash is 4 inches by 2 inches/ rash, bright red/ Rash erythematous and itchy rash/ Rash pruritic.   The patient's medical history, as provided by the reporter, included a bee sting allergy. The patient had Epinephrine handy for that but does not take any other meds No relevant concomitant medications were reported.   On 30 Dec 2020, approximately 9 days prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (039K20A) via unknown route in the right arm for prophylaxis of COVID-19 infection.   On 08 Jan 2021, the patient began to experience a bright red, itchy rash on her right arm. The size of the rash was about 4 inches by 2 inches. Treatment for the event included diphenhydramine hydrochloride, ibuprofen, and a cold compress.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, bright red, itchy rash, was considered recovering/resolving; Reporter's Comments: This case concerns a 46-year-old female who experienced NS events of unexpected rash pruritic and rash erythematous and expected rash.  Event onset occurred XX as / after the first dose of mRNA-1273. Treatment with diphenhydramine and ibuprofen. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
pt recv vax 12APR96 & 18APR96 pt devel a gen chickenpox rash w/60 lesions;It was noted that the pt had been exposed to natural chickenpox approx 4wk prior to vax;
A nurse reported that a 72 year old pt received an injection of Pnu-Imune 23 and influenza virus vaccine on 11/1/00. Subsequently, the pt developed cellulitis at the site of Pnu-Imune 23 administration. The pt was treated with an unspecified antibiotic. This is 1 of 3 pts from this facility who developed an injection site reaction following receipt of Pnu-Imune 23 (lot 470588). Follow-up information received from the physician on 3/14/01, indicated that a 72 year old female developed the adverse event on 11/2/00. She was seen by the physician and recovered.
I was fine until almost 12 hours later  I woke up feeling very dizzy and had a headache.  My head felt full.   I took Tylenol and didn't think much of it.  Later, at almost the 24 hour mark my R ear started ringing nonstop.  I had had a bout of Tinnitus once before, but it quickly went away a couple of hours later.   I figured this would do the same.  It has been almost 3 weeks now and my R ear has not stopped ringing.  I did a search and found that others, although rare have had similar issues, but most of them had this occur after the second vaccine.    This was my first vaccine.  I am a registered nurse and work in a busy ER and practically bathed in COVID all last year during the surges.  I do not know if I ever got COVID or not ,but if I did the symptoms were very mild.  I had a couple of colds, but other than that nothing big at all.
Vaccination was given a few days after beyond use date. Moderna was contacted and states the vaccination was safe and effective at the time given. No revaccination required. Patient reported having no adverse reactions.
7/18/99 pt exp fever & body aches; 7/20/99 devel vesicular rash on trunk & arms; no hx of wild type exposure; saw MD 7/21; preliminary labs indicate varicella zoster virus positive; MD rpt events considered disabling; 7/28/99 pt recovered;
2/4/2021 330pm 22 hours post vaccine, sweat running down my neck and back, stomach cramps, felt like I could get diarrhea any minute,  fever of 100.2, pounding headache  2/5/2021 1230am horrendous muscle cramps in my legs, back hurts so bad couldn't get out of bed 2/5/2021 11am felt dizzy and lightheaded, pounding headache came back
pt recvd vax 15OCT 230PM; 530PM pt noted chest pain, SOB, coughing; 730PM nausea, chills, vomiting, t103;
24 hours after vaccine broke out in rash - dime size red bumps. Itchy throat and extremities. Treatment: BEANDRYL, ice, cold bath, MEDROL dose pack. Pt began resolving in 72 hrs after vaccine.
The child experiencing vomiting and diarrhea approximately 8 1/2 hours after she was vaccinated. Mother noted that the patient never had a fever but her back and neck were hot to the touch. The patient is extremely weak and complains of feeling "achy".
about 10 mins after receiving vaccine, started feeling dizzy, and "swimmy" (tunnel vision, auditory fading), assisted to floor by staff, feet placed on chair. assisted to stretcher, placed in Trendelenburg, taken to obs, bp 107/70 hr 58 rr 18 sats 100% on ra. clamminess noted. water and snack provided, feeling better, sitting up vss, bp maintained. standing bp 118/81 15 mins later, other vss. escorted with sig other to exit with no issues after stating fully recovered